Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

155 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Investigation of Microbial Translocation, TLR and VDR Gene Polymorphisms, and Recurrence Risk in Stage III Colorectal Cancer Patients.
Messaritakis I, Koulouridi A, Boukla E, Sfakianaki M, Vogiatzoglou K, Karagianni M, Gouvas N, Tsiaoussis J, Xynos E, Athanasakis E, Mavroudis D, Tzardi M, Souglakos J. Messaritakis I, et al. Among authors: souglakos j. Cancers (Basel). 2022 Sep 10;14(18):4407. doi: 10.3390/cancers14184407. Cancers (Basel). 2022. PMID: 36139567 Free PMC article.
Dose-escalation study of docetaxel in combination with mitoxantrone as first-line treatment in patients with metastatic breast cancer.
Kouroussis C, Androulakis N, Kakolyris S, Souglakos J, Kotsakis T, Mavroudis D, Katsogridakis K, Vardakis N, Hatzidaki D, Samonis G, Vlachonikolis J, Georgoulias V. Kouroussis C, et al. Among authors: souglakos j. J Clin Oncol. 1999 Mar;17(3):862-9. doi: 10.1200/JCO.1999.17.3.862. J Clin Oncol. 1999. PMID: 10071277 Clinical Trial.
A dose-escalation study of irinotecan (CPT-11) in combination with cisplatin in patients with advanced non-small cell lung cancer previously treated with a docetaxel-based front line chemotherapy.
Kakolyris S, Souglakos J, Agelaki S, Kourousis CH, Mavroudis D, Sarra E, Malliotakis P, Georgoulias V. Kakolyris S, et al. Among authors: souglakos j. Lung Cancer. 2000 Dec;30(3):193-8. doi: 10.1016/s0169-5002(00)00146-x. Lung Cancer. 2000. PMID: 11137204 Clinical Trial.
Oxaliplatin in combination with infusional 5-fluorouracil and leucovorin every 2 weeks as first-line treatment in patients with advanced colorectal cancer: a phase II study.
Kouroussis C, Souglakos J, Kakolyris S, Mavroudis D, Malamos N, Kalbakis K, Androulakis N, Agelaki A, Vardakis N, Samonis G, Georgoulias V. Kouroussis C, et al. Among authors: souglakos j. Oncology. 2001;61(1):36-41. doi: 10.1159/000055350. Oncology. 2001. PMID: 11474246 Clinical Trial.
Salvage chemotherapy with high-dose leucovorin (LV) and 48-hour continuous infusion (CI) of 5-fluorouracil (5-FU) in combination with conventional doses of cyclophosphamide (CPM) in patients with metastatic breast cancer (MBC) pretreated with anthracycline and taxanes.
Kalbakis K, Kouroussis C, Kakolyris S, Mavroudis D, Souglakos J, Agelaki S, Vamvakas L, Christodoulakis M, Stylianou K, Georgoulias V. Kalbakis K, et al. Among authors: souglakos j. Br J Cancer. 2001 Sep 14;85(6):798-802. doi: 10.1054/bjoc.2001.2001. Br J Cancer. 2001. PMID: 11556827 Free PMC article. Clinical Trial.
Triplet combination with irinotecan plus oxaliplatin plus continuous-infusion fluorouracil and leucovorin as first-line treatment in metastatic colorectal cancer: a multicenter phase II trial.
Souglakos J, Mavroudis D, Kakolyris S, Kourousis Ch, Vardakis N, Androulakis N, Agelaki S, Kalbakis K, Tsetis D, Athanasiadis N, Samonis G, Georgoulias V. Souglakos J, et al. J Clin Oncol. 2002 Jun 1;20(11):2651-7. doi: 10.1200/JCO.2002.08.015. J Clin Oncol. 2002. PMID: 12039926 Clinical Trial.
155 results